表紙
市場調查報告書

EpiCast Report:多發性硬化症的流行病學預測

Multiple Sclerosis: Epidemiology Forecast to 2028

出版商 GlobalData 商品編碼 258690
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:多發性硬化症的流行病學預測 Multiple Sclerosis: Epidemiology Forecast to 2028
出版日期: 2019年11月29日內容資訊: 英文 38 Pages
簡介

多發性硬化症(MS)在全球每年影響250萬人,是青壯年中最大的衰弱性神經疾病。調查對象10個國家整體病例數2014年估計為909,398件,至2024年預計增加到942,567件。

本報告提供多發性硬化症(MS)的風險因素及全球趨勢的相關調查,主要8個市場(美國、法國、德國、義大利、西班牙、英國、日本、加拿大)及新興市場(印度、中國)的資料。

第1章 目錄

第2章 簡介

第3章 流行病學

  • 疾病的背景
  • 風險因素和共生病症
    • MS患者的家族持有MS發病的1%∼5%的風險
    • 女性MS發病的風險為2倍,可是男性預後不佳
    • 白種人(Caucasian)比其他人種/民族的MS風險高
    • 維他命D對MS的預防效果,可能與出生的地區、月份有關聯
    • 環境暴露的時機影響MS風險
    • 被動吸煙有可能增加MS風險,讓預後惡化
    • 自體免疫疾病可能成為MS的共生病症
    • 精神性共生病症在MS患者中最大60%,有可能影響復發率
  • 全球趨勢
    • 北美
    • 歐洲
    • 亞洲
  • 預測手法
    • 利用來源
    • 未利用的來源
    • 預測的前提條件、手法
  • 多發性硬化症的流行病學預測
    • 患病數
    • 患病數:各年齡
    • 患病數:性別
    • 發病數
    • 發病數:各年齡
    • 發病數:性別
    • 多發性硬化症的亞型
  • 考察
    • 流行病學趨勢的結論
    • 分析的限制
    • 分析的優勢

第4章 附錄

  • 參考資料
  • 關於作者
  • 關於GlobalData
  • 關於EpiCast
  • 免責聲明

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCER222-19

Multiple sclerosis (MS) is an autoimmune disease affecting principally the central nervous system that causes nerve sheath demyelination followed by axon damage and paralysis. MS symptoms include muscle weakness, weak reflexes, tremors, muscle spasm, prolonged double vision, slurred speech, and balance problems. MS can occur at any age, but commonly affects people of ages 15-60 years. The diagnosis of MS depends upon patients' symptoms, magnetic resonance imaging (MRI), and laboratory results, but it is mostly diagnosed in the late phases. Presently, MS is diagnosed by the widely used McDonald criteria, which is a combination of laboratory, clinical, and radiology reports of lesions at different times in different body areas.

GlobalData epidemiologists utilized county-specific studies published in peer-reviewed journals as well as medical record review studies to build the forecast. The disease definition for MS was consistent as per the McDonald criteria. The report includes a 10-year epidemiological forecast for the diagnosed incident and diagnosed prevalent cases of MS in the 7MM.

The following data describes epidemiology of MS. GlobalData epidemiologists forecast an increase in the diagnosed incident cases of MS in the 7MM from 53,299 cases in 2018 to 54,218 cases by 2028, at an AGR of 0.17% during the forecast period. The diagnosed prevalent cases of MS in the 7MM are expected to increase from 1,445,209 cases in 2018 to 1,595,707 cases by 2028, at an AGR of 1.04%. MS is more common in women than men and is more common in young adults. These trends are reflected in GlobalData's forecast for the diagnosed incident cases, and diagnosed prevalent cases for the 7MM.

Scope

  • The Multiple Sclerosis (MS) Epidemiology Report provides an overview of the risk factors and global trends of MS in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The report includes a 10-year epidemiological forecast for the diagnosed incident cases and diagnosed prevalent cases of MS segmented by sex, and age (all ages) in these markets. The diagnosed prevalent cases of MS are further segmented by type (relapsing-remitting [RRMS], primary progressive [PPMS], and secondary progressive [SPMS])
  • The multiple sclerosis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

RThe Multiple Sclerosis Epidemiology series will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global multiple sclerosis market.
  • Quantify patient populations in the global multiple sclerosis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for multiple sclerosis therapeutics in each of the markets covered.
  • Understand magnitude of multiple sclerosis population by severity at diagnosis.

Table of Contents

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Multiple Sclerosis: Executive Summary

  • 2.1 Related Reports
  • 2.2 Upcoming Reports

3 Epidemiology

  • 3.1 Disease Background
  • 3.2 Risk Factors and Comorbidities
  • 3.3 Global and Historical Trends
  • 3.4 Forecast Methodology
    • 3.4.1 Sources
    • 3.4.2 Forecast Assumptions and Methods
  • 3.5 Epidemiological Forecast for MS (2018-2028)
    • 3.5.1 Diagnosed Incident Cases of MS
    • 3.5.2 Age-Specific Diagnosed Incident Cases of MS
    • 3.5.3 Sex-Specific Diagnosed Incident Cases of MS
    • 3.5.4 Diagnosed Prevalent Cases of MS
    • 3.5.5 Age-Specific Diagnosed Prevalent Cases of MS
    • 3.5.6 Sex-Specific Diagnosed Prevalent Cases of MS
    • 3.5.7 Diagnosed Prevalent Cases of MS by Type
  • 3.6 Discussion
    • 3.6.1 Epidemiological Forecast Insight
    • 3.6.2 Limitations of Analysis
    • 3.6.3 Strengths of Analysis

4 Appendix

List of Tables

  • Table 1: Risk Factors and Comorbid Conditions Associated with MS

List of Figures

  • Figure 1: 7MM, Diagnosed Incident Cases of MS, N, Both Sexes, All Ages, 2018 and 2028
  • Figure 2: 7MM, Diagnosed Prevalent Cases of MS, N, Both Sexes, All Ages, 2018 and 2028
  • Figure 3: 7MM, Diagnosed Incidence of MS (Cases per 100,000 Population), Men and Women, All Ages, 2018
  • Figure 4: 7MM, Diagnosed Prevalence of MS (%), Men and Women, All Ages, 2018
  • Figure 5: 7MM, Sources Used and Not Used to Forecast the Diagnosed Incident Cases of MS
  • Figure 6: 7MM, Sources Used and Not Used to Forecast the Diagnosed Prevalent Cases of MS
  • Figure 7: 7MM, Sources Used and Not Used to Forecast the Diagnosed Prevalent Cases of MS by Type
  • Figure 8: 7MM, Diagnosed Incident Cases of MS, N, Both Sexes, All Ages, 2018
  • Figure 9: 7MM, Age-Specific Diagnosed Incident Cases of MS, N, Both Sexes, All Ages, 2018
  • Figure 10: 7MM, Sex-Specific Diagnosed Incident Cases of MS, N, All Ages, 2018
  • Figure 11: 7MM, Diagnosed Prevalent Cases of MS, N, Both Sexes, All Ages, 2018
  • Figure 12: 7MM, Age-Specific Diagnosed Prevalent Cases of MS, N, Both Sexes, All Ages, 2018
  • Figure 13: 7MM, Sex-Specific Diagnosed Prevalent Cases of MS, N, All Ages, 2018
  • Figure 14: 7MM, Diagnosed Prevalent Cases of MS by Type, N, Both Sexes, All Ages, 2018
Back to Top